US Stock MarketDetailed Quotes
GTHP GUIDED THERAPEUTICS INC
- 0.100000
- 0.0000000.00%
15min DelayClose Apr 25 16:00 ET
5.56MMarket Cap-1428P/E (TTM)
0.000000High0.000000Low2Volume0.100000Open0.100000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)55.61MShares0.30000052wk High-0.81P/B2.12MFloat Cap0.06200052wk Low--Dividend TTM21.21MShs Float0.800000Historical High--Div YieldTTM0.00%Amplitude0.062000Historical Low0.000000Avg Price1Lot Size
GUIDED THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 653.85%98K | 32K | 0 | 780.00%44K | 340.00%22K | -83.95%13K | 0 | -84.21%3K | 150.00%5K | 5K |
| Operating revenue | 653.85%98K | --32K | --0 | 780.00%44K | 340.00%22K | -83.95%13K | --0 | -84.21%3K | 150.00%5K | --5K |
| Cost of revenue | -23.46%62K | -79.75%16K | 4K | 3,200.00%33K | 800.00%9K | 32.79%81K | 315.79%79K | 0 | 1K | 1K |
| Gross profit | 152.94%36K | 120.25%16K | -233.33%-4K | 175.00%11K | 225.00%13K | -440.00%-68K | -292.68%-79K | 113.04%3K | 100.00%4K | 4K |
| Operating expense | 6.98%3.49M | -42.35%501K | -49.55%619K | 110.26%1.52M | 91.50%856K | 37.07%3.27M | 82.56%869K | 164.44%1.23M | 28.06%721K | -45.69%447K |
| Selling and administrative expenses | 2.42%3.27M | -50.00%415K | -54.88%550K | 103.65%1.45M | 99.30%849K | 37.83%3.19M | 80.83%830K | 172.10%1.22M | 31.12%712K | -47.21%426K |
| -Selling and marketing expense | 48.07%268K | 25.00%65K | 32.69%69K | 64.86%61K | 82.50%73K | 28.37%181K | 52.94%52K | 26.83%52K | 23.33%37K | 11.11%40K |
| -General and administrative expense | -0.33%3M | -55.01%350K | -58.78%481K | 105.78%1.39M | 101.04%776K | 38.44%3.01M | 83.06%778K | 186.73%1.17M | 31.58%675K | -49.94%386K |
| Research and development costs | 196.10%228K | 120.51%86K | 762.50%69K | 633.33%66K | -66.67%7K | 11.59%77K | 129.41%39K | -50.00%8K | -55.00%9K | 31.25%21K |
| Operating profit | -3.72%-3.46M | 48.84%-485K | 49.10%-623K | -109.90%-1.51M | -90.29%-843K | -41.11%-3.33M | -117.93%-948K | -151.33%-1.22M | -27.81%-717K | 46.17%-443K |
| Net non-operating interest income expense | 53.26%-272K | 5.71%-66K | 54.19%-71K | 73.05%-69K | 34.65%-66K | 49.39%-582K | 30.00%-70K | 73.91%-155K | 18.73%-256K | 28.37%-101K |
| Non-operating interest income | --6K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -52.23%278K | 2.86%72K | -54.19%71K | -73.05%69K | -34.65%66K | -49.39%582K | -30.00%70K | -73.91%155K | -18.73%256K | -28.37%101K |
| Other net income (expense) | 156.34%240K | 120.91%165K | -93.86%17K | -63.83%17K | 8.11%40K | -129.54%-426K | -967.03%-789K | -75.89%277K | 129.75%47K | -91.72%37K |
| Gain on sale of security | -81.48%5K | --0 | ---- | ---- | 183.33%5K | -92.44%27K | 800.00%14K | 600.00%5K | --14K | -101.67%-6K |
| Special income (charges) | 141.79%196K | 115.60%127K | -93.70%17K | -50.00%17K | -14.63%35K | -181.14%-469K | ---814K | -64.61%270K | 118.38%34K | -52.87%41K |
| -Less:Other special charges | -141.79%-196K | -115.60%-127K | 93.70%-17K | 50.00%-17K | 14.63%-35K | 181.14%469K | --814K | 64.61%-270K | -118.38%-34K | 52.87%-41K |
| Other non- operating income (expenses) | 143.75%39K | 245.45%38K | ---- | ---- | ---- | -96.84%16K | -88.17%11K | -99.48%2K | -103.70%-1K | --2K |
| Income before tax | 19.63%-3.49M | 78.64%-386K | 38.57%-677K | -68.14%-1.56M | -71.40%-869K | -109.71%-4.34M | -306.98%-1.81M | -1,720.59%-1.1M | 10.44%-926K | 1.93%-507K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 19.63%-3.49M | 78.64%-386K | 38.57%-677K | -68.14%-1.56M | -71.40%-869K | -109.71%-4.34M | -306.98%-1.81M | -1,720.59%-1.1M | 10.44%-926K | 1.93%-507K |
| Net income continuous Operations | 19.63%-3.49M | 78.64%-386K | 38.57%-677K | -68.14%-1.56M | -71.40%-869K | -109.71%-4.34M | -306.98%-1.81M | -1,720.59%-1.1M | 10.44%-926K | 1.93%-507K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.63%-3.49M | 78.64%-386K | 38.57%-677K | -68.14%-1.56M | -71.40%-869K | -109.71%-4.34M | -306.98%-1.81M | -1,720.59%-1.1M | 10.44%-926K | 1.93%-507K |
| Preferred stock dividends | -72.90%171K | -2.00%49K | 183.33%40K | -41.98%47K | -93.61%35K | 74.79%631K | -23.08%50K | -140.34%-48K | -35.20%81K | 896.36%548K |
| Other preferred stock dividends | 99K | 34K | 0 | 0 | 65K | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 24.40%-3.76M | 74.74%-469K | 31.97%-717K | -59.29%-1.6M | 8.15%-969K | -104.52%-4.97M | -264.83%-1.86M | -1,966.67%-1.05M | 13.11%-1.01M | -84.44%-1.06M |
| Basic earnings per share | 53.33%-0.07 | 0 | 66.67%-0.01 | 25.00%-0.03 | 60.00%-0.02 | 16.67%-0.15 | 0.00%-0.04 | -689.27%-0.03 | 55.56%-0.04 | -25.00%-0.05 |
| Diluted earnings per share | 53.33%-0.07 | 0 | 66.67%-0.01 | 25.00%-0.03 | 60.00%-0.02 | 16.67%-0.15 | 0.00%-0.04 | -689.27%-0.03 | 55.56%-0.04 | -25.00%-0.05 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg